About the Authors

Beáta Flachner

Affiliation TargetEx, Dunakeszi, Hungary

Zsolt Lörincz

Affiliation TargetEx, Dunakeszi, Hungary

Angelo Carotti

Affiliation Medicinal Chemistry Department, University of Bari “Aldo Moro”, Bari, Italy

Orazio Nicolotti

Affiliation Medicinal Chemistry Department, University of Bari “Aldo Moro”, Bari, Italy

Praveena Kuchipudi

Affiliation IMIM – Hospital del Mar Research Institute and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain

Nikita Remez

Affiliation IMIM – Hospital del Mar Research Institute and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain

Ferran Sanz

Affiliation IMIM – Hospital del Mar Research Institute and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain

József Tóvári

Affiliation National Institute of Oncology, Budapest, Hungary

Miklós J. Szabó

Affiliation AMRI Hungary Zrt., Budapest, Hungary

Béla Bertók

Affiliation AMRI Hungary Zrt., Budapest, Hungary

Sándor Cseh

Affiliation TargetEx, Dunakeszi, Hungary

Jordi Mestres

jmestres@imim.es (JM); dorman@target-ex.com (GD)

Affiliation IMIM – Hospital del Mar Research Institute and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain

György Dormán

jmestres@imim.es (JM); dorman@target-ex.com (GD)

Affiliation TargetEx, Dunakeszi, Hungary

Competing Interests

The authors have read the journal's policy and have the following conflicts: Beáta Flachner, Zsolt Lörincz, Sándor Cseh, and György Dormán are full-time paid employees of TargetEx, Dunakeszi, Hungary, and Miklós J. Szabó and Béla Bertók are full-time employees of AMRI Hungary Zrt., Budapest, Hungary. Jordi Mestres is President of Chemotargets SL. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: AC FS BB SC JM GD. Performed the experiments: BF ZL JT SC. Analyzed the data: JM GD. Wrote the paper: JM GD. Performed the calculations: ON PK NR MJS. All authors read and approved the final manuscript.